Quamed

07/01/2026

In December, QUAMED launched a technical support initiative for five French NGOs that are members of QUAMED.

This support aims to assist these organisations in their application to open a humanitarian pharmaceutical distribution establishment, authorised by the French National Agency for the Safety of Medicines and Health Products (ANSM).

The project focuses on:

- The development and strengthening of quality management systems,
- The preparation of regulatory dossiers for submission to the ANSM,
- As well as the external evaluation of these dossiers.

The project was officially launched through a two-day workshop held in Paris on 16–17 December 2025, bringing together the reference pharmacists from the participating NGOs. The workshop enabled the collective definition of the scope, governance, and implementation timeline of the project.

Anthony Bourasseau is acting as the expert mandated by QUAMED for the implementation of this initiative.

06/01/2026

The following message is courtesy of Dr Raffaella Ravinetto, Public Health Department, Institute of Tropical Medicine Antwerp, Belgium.

Register here: https://vive.nemtilmeld.dk/170/

01/01/2026

Happy New Year 2026! 🎉

Cheers to a new year of bold ideas, strong partnerships, and shared impact! Quamed wishes all our followers, partners, members, and friends a joyful, healthy, and inspiring 2026. Thank you for being part of our growing community. Let’s make this year even brighter together!

25/12/2025

🎄 Merry Christmas from Quamed 🎄

As we celebrate this festive season, we extend our heartfelt thanks to our partners and colleagues around the world. Your trust, collaboration, and shared commitment to quality healthcare make our work meaningful every day.

May this Christmas bring you peace, joy, and time to reflect on all we’ve achieved together. We look forward to continuing our collaboration and making an even greater impact in the year ahead.

✨ Merry Christmas and warm wishes from all of us at Quamed. ✨

18/12/2025

We’re delighted to share some great news 🎉🎉

QUAMED has officially issued a QCP GSDP certificate to Ltd. This certification recognises their compliance with the World Health Organisation’s Good Storage and Distribution Practices, reinforcing their commitment to quality, safety, and reliability across the supply chain.

We warmly congratulate Phillips Pharmaceuticals Ltd. (Zambia) and their dedicated team for reaching this important milestone. Their achievement reflects strong systems, responsible practices, and a shared mission to ensure access to quality-assured medical products.

You can find the certificate and more details on the QUAMED QCP: https://quamed.org/quality-certification-program/

17/12/2025

Strengthening Pharmaceutical Inspectors’ Skills in Benin

As part of the REG-PHARMA project, funded by the French Development Agency (AFD) and implemented by Expertise France, Quamed is supporting ABMed, the Pharmaceutical Regulatory Authority of Benin, to strengthen its inspectors’ skills in regulatory inspections, with a focus on pharmaceutical establishments (distributors and manufacturers).

Since July 2025, ABMed inspectors have participated in several GSDP and GMP audits conducted by Quamed.

- In November, 8 junior GSDP inspectors were trained through coached inspections with our auditors Laurine Lavergne and Jean-Christophe Pélissier.
- In January, 6 junior GMP inspectors will deepen their knowledge and apply it during coached inspections in Tunisia.


These activities enable inspectors to:

- Identify critical areas and risk points
- Apply risk-based inspection techniques
- Plan and conduct inspections using Quality Risk Management principles
- Prepare and categorise inspection observations and findings

They also help develop key skills: observation, questioning, triangulation, validation, critical thinking, communication, and decision-making.

Thank you to ABMed for their collaboration and to our auditors for their expert support!

09/12/2025

Diploma “Humanitarian Pharmacy and International Solidarity”

We had the pleasure of delivering, for the 3rd consecutive year, the module on the fundamentals of quality assurance applied to medical products within the University Diploma “Humanitarian Pharmacy and International Solidarity,” coordinated by Pharmacie Aide Humanitaire and the Faculty of Pharmacy of Lyon (France)

Our session aimed to enable participants to:

- Understand the essential principles of quality in the field of medical products

- Identify the main international standards and guidelines governing pharmaceutical quality

- Understand the regulatory framework related to the manufacture, control, and distribution of health products

- And ultimately apply this knowledge to real-life professional situations



This year, the 2025–2026 cohort brings together students from 7 nationalities, highlighting the richness and diversity of backgrounds committed to humanitarian pharmacy. Participants also received practical information on the DU (schedule, classroom access, connection links…) along with the cohort directory.



A warm thank you to all participants for the quality of the discussions and their strong engagement throughout the module.

This module offers a key opportunity to raise awareness of:

- The quality assurance challenges they will encounter in their future roles,

- The diverse regulatory environments they will work in,

So they can adopt the right practices to ensure the availability of quality-assured medical products wherever they serve.

We wish them all the very best for the continuation of their DU journey!

03/11/2025

Exciting News!

We’re thrilled to share that Washington DENGU will be joining QUAMED as Technical Deputy Director on a 0.5FTE basis starting November 1st!
Washington brings over 15 years of experience in pharmaceutical manufacturing and regulatory affairs, and continues to lead and shape Africa’s regulatory landscape actively. He brings in a wealth of experience, which includes coordination and leading of continental GMP inspections, regulatory harmonisation, pharmaceutical local production and building capacity for hundreds of regulators across Africa, all driven by a passion for ensuring access to safe, effective, and quality medicines.

At QUAMED, Washington will work closely with our team to strengthen quality assurance systems and advance our mission of improving global access to quality medicines.

Join us in welcoming Washington!

24/10/2025

We are proud that our courses have contributed to the professional development of the Autorité Congolaise de Réglementation Pharmaceutique staff. A great commitment from their side, with indispensable support from the DG, Dr Ntumba. We fully share VillageReach's belief that regulators are an essential part of the healthcare workforce. The only way the public can place trust in medicines is through a reliable regulatory authority. We are looking forward to future collaborations with ACOREP and with VillageReach.

VillageReach, through the Private Distributors project, believes that regulators are an essential part of the healthcare workforce and that ineffective regulatory systems can themselves be a barrier to access to quality, safe, and effective healthcare products. For nearly two months, we supported Ac...

24/10/2025

Access to essential medicines remains uneven worldwide. A study in India’s aspirational districts showed encouraging progress, with most treatments affordable and widely available. In stark contrast, Sudan’s civil war has led to severe shortages and unaffordable prices, leaving many without life-saving drugs. Meanwhile, Brazil continues to face systemic barriers, economic inequalities, import dependence, and limited R&D investment that restrict equitable access.

Together, these studies reveal that true progress toward “health for all” requires stronger systems, local production, and policies that make medicines both available and affordable for everyone.

Read these for more insights:

https://pubmed.ncbi.nlm.nih.gov/41089951

https://pubmed.ncbi.nlm.nih.gov/41094447

https://pubmed.ncbi.nlm.nih.gov/41088287

The policymakers should prioritize enhancing R&D investment, reducing dependency on international markets, strengthening regulatory frameworks, and improving health care system efficiency to ensure reliable access to essential medicines.

18/10/2025

Recrutement – Responsable Suivi, Évaluation, Redevabilité et Apprentissage (SERA)

L’UGP/Pharma à Dakar recrute un(e) Responsable SERA pour piloter le suivi, l’évaluation et l’apprentissage du projet de développement de l’industrie pharmaceutique locale. Profil recherché : Master en suivi-évaluation ou équivalent, minimum 5 ans d’expérience, excellentes compétences analytiques et rédactionnelles.

Date limite : 31 octobre 2025

Postulez ici :

1. CONTEXTE En 2024, le Sénégal a adopté un nouveau référentiel de politiques publiques dénommé “Agenda national de Transformation systémique du Sénégal ” pour un Sénégal souverain, juste et prospère. Cette ambition est traduite dans la Stratégie nationale de développement 2025-20...

17/10/2025

The World Health Organization (WHO) has issued a warning after detecting Diethylene Glycol (DEG) contamination in three oral liquid medicines, COLDRIF, Respifresh TR, and ReLife, linked to child fatalities in India. These products, commonly used for cold, flu, and cough relief, are toxic and potentially fatal, especially for children. While no exports have been reported, WHO urges all countries to remain vigilant, enhance market surveillance, and immediately report any suspicious products.

Avoid using these medicines and seek medical help if exposed.

Read more: https://www.who.int/news/item/13-10-2025-medical-product-alert-n-5-2025--substandard-(contaminated)-oral-liquid-medicines

Alert summaryThis WHO Medical Product Alert refers to three substandard (contaminated) oral liquid medicines identified in India and reported to WHO on 8 October 2025.The affected products are oral liquid medicines containing active ingredients commonly used to relieve symptoms of the common cold, f...